Skip to main content
Year archive

Sihuan Pharmaceutical Holdings Group Ltd. — 2019 filings

All 45 regulatory filings released by Sihuan Pharmaceutical Holdings Group Ltd. (460) in 2019, sourced directly from the official regulator.

45 Filings
2019 Period
2019 filings (45)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2019
Share Issue/Capital Change
2019-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2019
Share Issue/Capital Change
2019-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2019
Capital/Financing Update
2019-10-02 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2019-09-13 English
Notification Letter and Change Request Form to Shareholder
Report Publication Announcement
2019-09-13 English
Interim Report 2019
Interim / Quarterly Report H1 2019
2019-09-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2019
Capital/Financing Update
2019-09-02 English
Voluntary Announcement Drug Registration Approval Granted for Quetiapine Fumarate ER Tablet Jointly Developed with PharmaDax (FoShan) Co., Ltd.
Regulatory Filings
2019-08-27 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2019
Interim / Quarterly Report H1 2019
2019-08-19 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-08-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2019
Share Issue/Capital Change
2019-08-01 English
VOLUNTARY ANNOUNCEMENT ESTABLISHMENT OF JOINT VENTURE WITH STRIDES LIMITED FOR SUPPLYING AND DISTRIBUTING FOUR DRUGS IN THE PRC
Regulatory Filings
2019-07-29 English
PROFIT WARNING - MAINLY ATTRIBUTABLE TO WRITE-OFF OF GOODWILL
Regulatory Filings
2019-07-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2019
Regulatory Filings
2019-07-02 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2019-06-24 English
Sihuan Pharmaceutical has been Granted the Drug Registration Approval for Another Solid-Liquid Double Chamber Bag, and is the First Company in China that obtained Drug Registration Approval for &#x2
Regulatory Filings
2019-06-19 English
Voluntary Announcement - Sihuan Pharmaceutical is the First Company in China that has been Granted the Drug Registration Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Cefodizime So
Regulatory Filings
2019-06-17 English
Next Day Disclosure Return
Share Issue/Capital Change
2019-06-11 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2019-06-09 English
Next Day Disclosure Return
Share Issue/Capital Change
2019-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2019
Share Issue/Capital Change
2019-06-03 English
Voluntary Announcement Post-launching Large-scale Clinical Trials of Cinepazide Maleate Injection were Completed With Efficacy Verified
Regulatory Filings
2019-05-31 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 31 MAY 2019 AND DIVIDEND PAYMENT
Declaration of Voting Results & Voting Rights Announcements
2019-05-31 English
Voluntary Announcement Sihuan Pharmaceutical has Acquired Phase I to III Clinical Trial Approval for the Third Generation of EGFR Inhibitor XZP-5809
Regulatory Filings
2019-05-29 English
Voluntary Announcement Sihuan Pharmaceutical is the First Company in China that has been Granted a Non-PVC Solid-Liquid Double Chamber Bag Drug Registration Approval for "Non-PVC Solid-Liquid
Regulatory Filings
2019-05-27 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
Regulatory Filings
2019-05-02 English
Notification Letter and Request Form to Non-registered Holder
Report Publication Announcement
2019-04-26 English
Notification Letter and Change Request Form to Shareholder
Report Publication Announcement
2019-04-26 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2019-04-26 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-26 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2019-04-26 English
Annual Report 2018
Annual Report FY 2018
2019-04-26 English
VOLUNTARY ANNOUNCEMENT - Early Completion of Patient Recruitment for Phase II Clinical Trial in China for Anaprazole Sodium, a Patented Innovative Digestive System Drug researched and developed by Sih
Regulatory Filings
2019-04-25 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
Regulatory Filings
2019-04-01 English
VOLUNTARY ANNOUNCEMENT Acceptance of First Application for Production Approval in respect of Sihuan Pharmaceutical Product "Eslicarbazepine Acetate"
Regulatory Filings
2019-03-20 English
VOLUNTARY ANNOUNCEMENT - Patented Innovative Oncology Drug Birociclib Achieved Breakthrough in Phase I Clinical Trial
Regulatory Filings
2019-03-19 English
Nomination Committee Terms of Reference Adopted by the Board on 8 October, 2010 and Amended by the Board on 19 March 2012, 18 March 2019
Governance Information
2019-03-19 English
Voluntary Announcement - Progress in Phase III Clinical Trial in China of Sihuan Pharmaceutical's Anti-diabetic Drug Insulin Analogue "Insulin Aspart, Insulin Aspart 30"
Regulatory Filings
2019-03-18 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report FY 2018
2019-03-18 English
Voluntary Announcement - Compound Amino Acid Injection (20AA) of Sihuan Pharmaceutical Granted Approval for Drug Registration
Regulatory Filings
2019-03-18 English
NOTICE OF BOARD MEETING
Regulatory Filings
2019-03-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2019
Share Issue/Capital Change
2019-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2019
Share Issue/Capital Change
2019-02-01 English
VOLUNTARY ANNOUNCEMENT - Sihuan Pharmaceutical's First Anti-diabetic Innovative Patented New Drug Janagliflozin Commenced Phase III Clinical Trial in China
Regulatory Filings
2019-01-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2018
Capital/Financing Update
2019-01-02 English